Evidence map›Paper›PMID 36480066›Full record

ArticleVirchows Archiv : an international journal of pathology2023

Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence.

Elena Sabattini, Clara Bertuzzi, Alessandro Broccoli, Claudio Agostinelli, Anna Gazzola, Claudia Mannu, Simona Righi, Emanuela Ottaviani, Carolina Terragna, Giovanna Motta and 4 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Elena SabattiniHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Via Massarenti 9, 40138, Bologna, Italy. elena.sabattini@aosp.bo.it.ORCID http://orcid.org/0000-0002-4136-3591
Clara BertuzziHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Alessandro BroccoliIRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia "Seràgnoli", Bologna, Italy.
Claudio AgostinelliHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Anna GazzolaHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Claudia MannuHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Simona RighiDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Emanuela OttavianiIRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia "Seràgnoli", Bologna, Italy.
Carolina TerragnaIRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia "Seràgnoli", Bologna, Italy.
Giovanna MottaPathology Unit, Ospedale Maggiore, Bologna, Italy.
Federica MellePathology Unit, Ospedale Maggiore, Bologna, Italy.
Costantino RicciPathology Unit, Ospedale Maggiore, Bologna, Italy.
Francesca AmbrosiPathology Unit, Ospedale Maggiore, Bologna, Italy.
Stefano A PileriDivision of Haematopathology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
Azienda USL di Bologna · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIstituto di Ematologia di Bologna · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extranodal T-lymphoproliferative disorders or T-cell lymphomas (TLPD) are classified according to the WHO Classification (4th and upcoming 5th editions) (Swerdlow et al., IARC Press 1; Alaggio et al., Leukemia 36(7):1720-1748, 2) and to the International Consensus Classification Update (Campo et al., Blood 140(11):1229-1253, 3) upon several morphologic, phenotypic, and genetic features. None of those at present included has been characterized by primary pulmonary onset. We herein present two such cases which, to the best of our knowledge, have not been previously reported and that might represent another variant of T-cell proliferation at mucosal sites. The two cases share similar histological and phenotypic features, suggesting an origin from CD4 + effector memory T cells with the expression of a CD279/PD-1 antigen. They are both monoclonal, harbor few mutations, and show no disease progression outside the lung. They only differ concerning the local extension of the process and clinical setting. The two cases are examples of so far unreported primary pulmonary TLDP, with limited stage and low proliferative index. A possible relationship with a local yet unknown inflammatory trigger that might have favored the development of the T-cell clone cannot be ruled out.

Indexed as

Lymphoma, T-CellLymphoproliferative DisordersHumansLungMucous MembraneT-LymphocytesLimited stageLungPrimaryT-cell lymphoproliferative disorderT-helper follicular

Identifiers

PMID36480066
OpenAlexW4310938673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.